Suppressing puberty in gender-dysphoric children by administering puberty blockers entails several known risks including decreased bone density. A new study found that after 2 years on GnRHas, up to 1/3 of the children have abnormally low bone density. /1https://t.co/i8ylAvWMyg

— SEGM (@segm_ebm) May 3, 2021